SBI Securities’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$50 Sell
6
-27
-82% -$194 ﹤0.01% 3732
2026
Q2
$190 Sell
33
-12
-27% -$61 ﹤0.01% 3344
2026
Q1
$223 Buy
45
+4
+10% +$19 ﹤0.01% 3182
2025
Q4
$191 Buy
41
+40
+4,000% +$181 ﹤0.01% 3226
2025
Q3
$5 Buy
+1
New +$3 ﹤0.01% 4108

Other funds holding SOPH

SBI Securities's SOPH Position: Q3 2026 in Review

SBI Securities reduced its SOPHiA GENETICS (SOPH) stake by 82% in Q3 2026, selling an estimated $194 and leaving 6 shares worth $50. The position accounts for ﹤0.01% of the portfolio, ranked #3732.

SBI Securities first reported a position in SOPH in Q3 2025 and has held it in 5 quarters since. The position peaked at $223 in Q1 2026. 10 funds tracked by Wall St. Rank hold SOPH as of Q3 2026.

  • SBI Securities held 6 shares of SOPHiA GENETICS worth $50 as of Q3 2026.
  • SBI Securities sold 27 SOPHiA GENETICS shares in Q3 2026, an estimated $194.
  • SOPHiA GENETICS made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3732 holding.
  • SBI Securities first reported a position in SOPHiA GENETICS in Q3 2025 and has held it in 5 quarters since.
  • SBI Securities's SOPHiA GENETICS position peaked at $223 in Q1 2026.
  • 10 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.